Further Information

Privacy Policy: Consilient Health Ltd will always employ appropriate technical security measures to protect your personal information and to ensure that it is not accessed by unauthorised persons. Consilient Health Ltd respects the confidentiality of personal information. Only Consilient Health Ltd will have access to your information. Your information will not be disclosed or sold to any other third parties such as outside mailing organisations. If at any time you require your information on the Consilient Health Ltd database to be amended, or that you wish to unsubscribe from the prospective delivery of promotional emails, please email irishoffice@consilienthealth.com. Additional information on our privacy policy can be requested at Consilient Health Ltd, Block 2A, Richview Office Park, Clonskeagh, Dublin14, Ireland.

IE/MYS/1017/0076f | Date of preparation: October 2017

 Mysimba® is subject to additional monitoring. To report an adverse event or a product complaint about Mysimba®, please contact: HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; e-mail: medsafety@hpra.ie Adverse events should also be reported to Orexigen®: 1-800-902-210 or Mysimba@druginfo.com.

For all other queries, please contact our Irish office at Tel: +353 (0)1 2057760, Fax: +353 (0)1 2698919 or irishoffice@consilienthealth.com

Copyright ©2017 Consilient Health. All rights reserved.

The information on this website is intended for healthcare professionals registered in the Republic of Ireland only.